Weili Wang

Weili Wang is a Senior Investment Associate at Atlantic Bridge, where she focuses on early-stage venture capital investments in the technology and life sciences sectors. She joined the firm's University Bridge Fund in 2021 to lead investment evaluation and deal sourcing across deep tech and biotech markets. Previously, Wang served as a Biotech Investment Fellow at M Ventures, the corporate venture capital arm of Merck KGaA, where she evaluated emerging life science opportunities. Her earlier career includes technology transfer and commercialization roles at the University of Queensland, as well as advisory experience at KPMG and Independent Innovation Centres. She holds two Master's degrees in Molecular Biology and Technology and Innovation Management from the University of Queensland. Wang leverages her dual expertise in molecular biology and commercial strategy to identify and scale early-stage biotech and technology enterprises.